Type
1.
Wen-Zhong L, Gan-Yun Y. [Results of six-month treatment of paucibacillary leprosy patients with rifampicin and dapsone]. Chinese Journal of Dermatology. 1988;21(6):355-7.
Type
1.
Vargas LCO, Rueda AG, Becerra X, Moreno EJ, León LDS. [Associated factors with irregular intake of Dapsone in leprosy patients]. Revista de la Universidad Industrial de Santander. Salud [Internet]. 2013;45(1):7-14. Available from: http://www.scielo.org.co/pdf/suis/v45n1/v45n1a02.pdf
Type
1.
Illarramendi X, Oliveira MLW- del-R de, Sales AM, Costa Nery JA, Sarno EN. Considerations on clinical trials of leprosy treatment: need of novel drug combinations. Clinical Investigation [Internet]. 2013;3(7):617-35. Available from: http://www.future-science.com/doi/pdf/10.4155/cli.13.52
Type
1.
Girão RJ, Soares NL, Pinheiro JV, Oliveira G, Carvalho SM, Abreu LC, et al. Leprosy treatment dropout: a sistematic review. International Archives of Medicine [Internet]. 2013;6(1):34. Available from: http://www.intarchmed.com/content/pdf/1755-7682-6-34.pdf
Type
1.
Editor’s Choice June 2012: Scales for measuring everything. Leprosy review. 2012;83:119-20.
Type
1.
Oliveira DT, Sherlock J, Melo EV, Rollemberg KCV, Paixão TRS, Abuawad YG, et al. Clinical variables associated with leprosy reactions and persistence of physical impairment. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2013;46(5):600-4. Available from: http://www.scielo.br/pdf/rsbmt/v46n5/0037-8682-rsbmt-42-2013.pdf
Type
1.
Chakraborty, Chakraborty, Sengupta. Successful treatment of osteomyelitis in leprosy patients by homeopathic medicine. Exploratory Animal and Medical Research [Internet]. 2013;3(2):169-77. Available from: http://animalmedicalresearch.org/Vol.3_Issue-2_December_2013/D%20Chakraborty.pdf
Type
1.
Koval, Vlasov, Shichkova, Khunderyakova, Markov, Panchenko, et al. Anti-leprosy drug Clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Biochemical pharmacology. 2013;.
Type
1.
Santos M, Franco EDS, Ferreira PLC, Braga WSM. Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin. Anais brasileiros de dermatologia [Internet]. 2013;88(6 Suppl 1):109-12. Available from: http://www.scielo.br/pdf/abd/v88n6s1/0365-0596-abd-88-06-s1-0109.pdf
Type
1.
Peixoto AB, Portela PS, Leal FRPC, Brotas AM, Rodrigues NCDS. Lucio’s Phenomenon. Case study of an exceptional response to treatment exclusively with multibacillary multidrug therapy. Anais brasileiros de dermatologia [Internet]. 2013;88(6 Suppl 1):93-6. Available from: http://www.scielo.br/pdf/abd/v88n6s1/0365-0596-abd-88-06-s1-0093.pdf